BIOLASE (BIOLQ) Stock Statistics & Valuation Metrics

BIOLASE has a market cap or net worth of $37.00. The enterprise value is $16.44.

BIOLASE has 36,597,336 shares outstanding. The number of shares has decreased by -2.65% in one year.

BIOLASE’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.

The current PE Ratio of BIOLASE is ―. BIOLASE’s PEG ratio is ―.

In the last 12 months, BIOLASE had revenue of ― and earned -20.63M in profits. Earnings per share was ―.

In the last 12 months, operating cash flow was ― and capital expenditures ―, giving a free cash flow of ― billion.

BIOLASE pays an annual dividend of ―, resulting in a dividend yield of ―

BIOLASE upcoming earnings date is Aug 7, 2025, Before Open (Confirmed).

BIOLASE as a current ratio of ―, with Debt / Equity ratio of ―

In the past 12 months, BIOLASE has paid ― in taxes.

BIOLASE EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.

BIOLASE has ― in cash and marketable securities with ― in debt, giving a net cash position of ― billion.

Gross margin is ―, with operating margin of ―, and net profit margin of ―.

The average price target for BIOLASE is ―, which is 11.43% higher than the current price. The consensus rating is ―